DLBCL, Diffused Large B Cell Lymphoma
2 clinical trials · Condition
◉ Watch DLBCL, Diffused Large B Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma (NCT03207867) | Novartis Pharmaceuticals | 2017-08-28 |
Track DLBCL, Diffused Large B Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.